UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
FDA warns against possible link between death and feeding tubes
The U.S. Food and Drug Administration (FDA) issued a safety alert regarding...
by Lee Han-soo
|
2018-01-12 16:21
라인
Ministry issues cold-related illness advisory
The Korea Centers for Disease Control and Prevention (KCDC) advised the pub...
by Lee Han-soo
|
2018-01-12 14:36
라인
Public hearing to discuss support plans for healthcare industry
The Ministry of Health and Welfare (MOHW) said it would convene a public he...
by Lee Han-soo
|
2018-01-10 16:17
라인
Vieworks unveils bio-imaging equipment
Vieworks, which specializes in medical imaging, said Wednesday that it has ...
by Lee Han-soo
|
2018-01-10 14:07
라인
U&I gets FDA nod for facet screw fixation system
U&I Corp. said Tuesday that it has received the U.S. Food and Drug Administ...
by Lee Han-soo
|
2018-01-10 10:25
라인
Rayence to set up production base in Brazil
Rayence, a Korean company, specializing in digital X-ray imaging solution, ...
by Lee Han-soo
|
2018-01-10 10:25
라인
Ministry orders recall on Israeli gel
The Ministry of Food and Drug Safety (MFDS) said Tuesday that it has ordere...
by Lee Han-soo
|
2018-01-09 17:52
라인
Bio-shares on the rise
Bio-industry shares are on the rise amid expectations for favorable governm...
by Lee Han-soo
|
2018-01-09 15:26
라인
GC Pharma’s high-content vitamin becomes blockbuster drug
GC Pharma said Monday that B-Max, a high-content vitamin, has become a bloc...
by Lee Han-soo
|
2018-01-09 11:49
라인
Ministry contest to fund bio-industry R&D
The Ministry of Science and ICT (MSIT) said Monday that it would hold its f...
by Lee Han-soo
|
2018-01-09 11:15
라인
SMC performs over 300 hybrid atrial fibrillation ablation
The Samsung Medical Center's (SMC) cardiology department said Monday th...
by Lee Han-soo
|
2018-01-08 16:58
라인
SillaJen dismisses allegations against its foreign patents
SillaJen denied recent allegations regarding problems with its foreign pate...
by Lee Han-soo
|
2018-01-08 14:30
라인
Celltrion’s market cap exceeds 36 trillion won
Celltrion has emerged as the fourth largest company by market capitalizatio...
by Lee Han-soo
|
2018-01-08 12:27
라인
Korean pharmaceuticals expect to raise US market share
Domestic pharmaceutical companies are expecting to grow their U.S. market s...
by Lee Han-soo
|
2018-01-05 17:17
라인
SNUH team develops new nanomaterial for thermal cancer therapy
The Seoul National University Hospital (SNUH) said Friday it has developed ...
by Lee Han-soo
|
2018-01-05 15:13
라인
Celltrion stocks jump on expectations of rising market share
Investors are paying attention to Celltrion, the local leader in the develo...
by Lee Han-soo
|
2018-01-04 16:40
라인
Toshiba Medical Systems changes its name to Canon Medical Systems
Canon, a Japanese multinational corporation, announced Thursday that it cha...
by Lee Han-soo
|
2018-01-04 12:53
라인
SNUBH reduces hospitalization period with ‘AMU’ system
The Seoul National University Bundang Hospital (SNUBH) said Thursday it has...
by Lee Han-soo
|
2018-01-04 11:37
라인
Regulators okay Abbott Korea’s house dust mite allergy treatment
The Ministry of Food and Drug Safety (MFDS) has approved Abbott Korea’s Aca...
by Lee Han-soo
|
2018-01-03 17:38
라인
Samyang Biopharm wins patent suit against Helsinn Healthcare
Samyang Biopharm said Wednesday that it has won a patent suit on Palseron (...
by Lee Han-soo
|
2018-01-03 16:58
-
이전
101
102
103
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top